Is There a “Blind Spot” in Point-of-Care Testing for Residual Heparin After Cardiopulmonary Bypass? A Prospective, Observational Cohort Study

Is There a “Blind Spot” in Point-of-Care Testing for Residual Heparin After Cardiopulmonary Bypass? A Prospective, Observational Cohort Study

Identifying the cause of a bleeding complication after cardiac surgery can be crucial. This study sought to clarify whether the application of unprocessed autologous pump blood influences anti-factor Xa activity after cardiac surgery and evaluated 2 point-of-care methods regarding their ability to i...

Full description

Bibliographic Details
Main Authors: Saskia Wand MD, Daniel Heise MD, Nadine Hillmann MD, Christian Bireta MD, Anselm Bräuer MD, Nicolas von Ahsen MD, Michael Quintel MD
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029620946843

Internet

https://doi.org/10.1177/1076029620946843

Similar Items